Conference
Phase I study to determine the safety and pharmacokinetics of BAY 43-9006 in patients with advanced refractory solid tumors.
Authors
Hirte H; Moore MJ; Oza AM; Siu LL; Harris H; Maclean M; Petrenciuc O; Fiander W; Lathia C
Volume
7
Pagination
pp. 3768S-3768S
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
11 2001
Conference proceedings
CLINICAL CANCER RESEARCH
Issue
11
ISSN
1078-0432